A groundbreaking study published in Nature highlights a major advancement in global genomics, with thousands of African genomes now enriching international genetic databases. The research details the launch and success of the Assessing Genetic Diversity in Africa (AGenDA) project—a nine-country collaboration designed to deepen scientific understanding of human genetic diversity and its impact on disease.
The AGenDA initiative has generated whole-genome sequence data from more than 1,000 individuals belonging to communities historically underrepresented in genomic research. This effort is expected to uncover millions of previously unknown genetic variants, paving the way for more accurate disease risk prediction and personalized treatments for conditions such as cancer, diabetes, mental illness, and heart disease.
Spanning Angola, the Democratic Republic of Congo, Kenya, Libya, Mauritius, Rwanda, Tunisia, and Zimbabwe—with coordination from South Africa—the project represents a truly collaborative, African-led scientific effort. It includes diverse population groups such as hunter-gatherer communities, Nilo-Saharan and Afro-Asiatic speakers, understudied Bantu-speaking groups, and populations from North Africa and Indian Ocean islands.
“Most genomic datasets used in modern medicine are heavily Eurocentric, limiting their effectiveness in predicting disease risk in African populations,” said Michèle Ramsay, Director of the Sydney Brenner Institute for Molecular Bioscience at Wits University and lead author of the study. “AGenDA addresses this imbalance by increasing African representation in global datasets.”
African genomes are the most diverse in the world, often showing greater variation within the continent than between populations from other regions. Without adequate African data, genetic tools risk missing critical variants, leading to less accurate diagnoses and treatments.
“AGenDA is about ensuring that genomic research benefits African populations while improving medical science globally,” said Furahini Tluway, Project Coordinator at SBIMB. By focusing on whole-genome sequencing, the project provides rich datasets that scientists worldwide can utilize.
The initiative also enhances the accuracy of genome-wide association studies (GWAS), which rely on identifying genetic patterns linked to diseases. “Without African data, these models remain biased,” noted Scott Hazelhurst, Head of Bioinformatics at SBIMB. “AGenDA makes these tools more scientifically robust and ethically sound.”
Beyond scientific contributions, AGenDA sets a benchmark for ethical research governance. Led by African scientists, the project emphasizes community engagement, culturally sensitive consent processes, and African-controlled data access. This ensures participants are active partners rather than passive subjects, safeguarding against historical data exploitation.
AGenDA builds on the foundation laid by the Human Heredity and Health in Africa Consortium, a pan-African program advancing genomic research capacity. It also complements initiatives like AWI-Gen, which examines cardiometabolic diseases across African populations.
In the long term, AGenDA will contribute to the development of African genetic reference databases, improving disease research, diagnostics, and treatments worldwide. As Ananyo Choudhury, co-lead of the project, explains, the initiative fills critical geographic and ethnolinguistic gaps in global genomic datasets.
Ultimately, studying African genetic diversity not only benefits the continent but also strengthens global medical science. “Because African genomes contain the deepest branches of human genetic history, they help us better understand which genetic variants truly influence disease,” Ramsay concluded.
